Tools   Select Another Resource Report Type

http://www.scienceexchange.com/facilities/the-university-of-texas-southwestern-medical-center-at-dallas

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 22, 2024. Portal, Core facility

Proper citation: University of Texas Southwestern Medical Center at Dallas Labs and Facilities (RRID:SCR_012474) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-western-sydney

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 15,2024. Portal, Core facility

Proper citation: University of Western Sydney Labs and Facilities (RRID:SCR_012590) Copy   

•   Source: SciCrunch Registry

http://www.sciexnceexchange.com/facilities/qfab-bioinformatics

Core facility providing support in bioinformatics, biostatistics and biodata to life sciences and health researchers across Queensland and beyond. Services include microarrays, next generation sequencing and proteomics profiling, biostatistical support from design of experiments, to analysis and interpretation, help High Degree Research students and Early Career Researchers in management, mining and visualization of small and big data, leveraging the cloud and hpc research infrastructure powered by the Queensland Cyber Infrastructure Foundation., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.

Proper citation: QFAB Bioinformatics (RRID:SCR_012513) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/tulane-university-school-of-medicine

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 19,2024. Portal, Core facility

Proper citation: Tulane University School of Medicine Labs and Facilities (RRID:SCR_012516) Copy   

•   Source: SciCrunch Registry

https://www.scienceexchange.com/labs/virginia-bioinformatics-institute-vt

THIS RESOURCE IS NO LONGER IN SERVCE, documented January 23, 2019. Core functions as a multi-user resource dedicated to the development and application of various high-throughput technologies to aid in the discovery of biological macromolecules. Core provides analysis platforms for DNA (sequencing and genotyping), RNA (gene expression analysis) and proteins (proteomics). They also offer a selection of molecular biology applications (colony picking, cloning, DNA/RNA isolations).

Proper citation: Virginia Bioinformatics Institute (RRID:SCR_012636) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/oregon-health-science-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on December 5, 2022. An Portal, Core facility

Proper citation: Oregon Health and Science University Labs and Facilities (RRID:SCR_012517) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/advanced-cell-diagnostics-inc

A molecular pathology company that sells tissue-based diagnostic tests for personalized medicine.

Proper citation: Advanced Cell Diagnostics (RRID:SCR_012481) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-health-network

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 19,2024. Portal, Core facility

Proper citation: University Health Network Labs and Facilities (RRID:SCR_012483) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/medros-inc

An Core facility

Proper citation: Medros (RRID:SCR_012400) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/duke-university

An Portal, Core facility

Proper citation: Duke University Labs and Facilities (RRID:SCR_012445) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/am-biotechnologies-llc

AM Biotechnologies develops DNA-based affinity agents called thioaptamers using unique chemistries and a proprietary bead-based selection process. Antibodies are currently the most widely-used affinity agents but they are produced in animals; are easily degraded; are expensive to produce; and suffer from batch-to-batch variability. In contrast, thioaptamers are chemically synthesized; they are stable in ambient environments with very long shelf life; and are rapidly produced in large quantities with easy quality control. We solve the problems associated with antibodies while delivering the same functionality. Thioaptamers can be substituted for antibodies in virtually any application. We can develop thioaptamer affinity agents for your targets using our bead-based development service. AM also offers DNA thiophosphoramidite reagents via a strategic partnership with Glen Research Corporation and the RNA thiophosphoramidites are near market introduction. These unique reagents are used to synthesize thioaptamers and are also highly useful for providing in vivo stability and increased potency in RNAi applications. The company was founded in 2006 and is primarily owned by two corporations. It has been awarded numerous SBIR grants and has also benefited from over $10M of prior university research into its technologies. Importantly, all of our technologies have freedom to operate.

Proper citation: AM Biotechnologies (RRID:SCR_012568) Copy   

•   Source: SciCrunch Registry

http://www.dkpgenomics.com/

Core facility provides resources to researches in the bioinformatics field. Core also provides assistance in generating omics data, data analysis, biological interpretations, and infrastructure.

Proper citation: DKP Genomics (RRID:SCR_012604) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/american-peptide-company

American Peptide Company, Inc. (APC) offers comprehensive selections of pre-manufactured catalog peptides, custom synthesis, and GMP peptide Active Pharmaceutical Ingredients. Our California based manufacturing facilities offer synthesis services under Non GMP (Sunnyvale, California) and cGMP (Vista, California) conditions. Our cGMP manufacturing is performed under strict adherence to FDA Regulations 21 CFR parts 210, 211 and ICH Guidance Q7A. Our Total Peptide Management services support clients in the drug development process from pre-clinical through commercial stage. Our value added services include process development, scale up production, analytical/process validation, stability studies, CMC, DMF, and regulatory support.

Proper citation: American Peptide Company (RRID:SCR_012606) Copy   

•   Source: SciCrunch Registry

https://www.thebestgene.com/

We provide high quality Drosophila transgenic service to both research institutions and companies. We offer you partial to full service ranging from DNA preparation, embryo microinjection, screening for white+, yellow+, and/or GFP/RFP phenotypes, to balancing crosses. Most importantly, the cost of our Drosophila embryo injection services is more reasonable compared to that of others. With a large number of facilities and the highly experienced staff, we are able to initiate the process immediately upon receiving your sample. Our friendly web-based database allows you to track your sample status, service history and more.

Proper citation: BestGene (RRID:SCR_012605) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-nebraska-medical-center

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, core facility.

Proper citation: University of Nebraska Medical Center Labs and Facilities (RRID:SCR_012451) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/advanced-bioscience-laboratories

Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, partnering with our clients to advance their vaccine and therapeutic development programs. Our unique combination of preclinical and clinical services provide the tools to address the scientific challenges encountered during any stage of product development. For preclinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. Once a clinical candidate is identified, ABL''s in-house cGMP suites are designed for single-use technologies accommodating a wide range of products, including mammalian- and microbial-based protein therapeutics as well as viral vectors and vaccines.

Proper citation: Advanced BioScience Laboratories (RRID:SCR_012576) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/university-of-rochester

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 16,2024. Portal, Core facility

Proper citation: University of Rochester Labs and Facilities (RRID:SCR_012454) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/cornell-university

An Portal, Core facility

Proper citation: Cornell University Labs and Facilities (RRID:SCR_012457) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/the-ohio-state-university

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 22, 2024. Portal, Core facility

Proper citation: Ohio State University Labs and Facilities (RRID:SCR_012462) Copy   

•   Source: SciCrunch Registry

http://www.scienceexchange.com/facilities/biotrend-chemikalien-gmbh-cologne

After more than a decade of experience in the sale and marketing of research products for Life Science Research, Werner Hassler, Switzerland and Gunther Jaeger, Germany founded the Cologne based BIOTREND Chemikalien GmbH in May 1988. BIOTREND was instigated in order to meet the growing demand from customers for an independent and technologically orientated distribution facility offering high quality, yet cost-effective products for biochemical, immunochemical and pharmaceutical research. Through our innovative strength we are not only providing our customers a vast product range, but also a high quality, first-class service package. At present we offer more than 90.000 products that have successfully been implemented not only in the drug discovery market, but also in cancer research as well as other scientific fields.

Proper citation: BIOTREND Chemikalien GmbH (RRID:SCR_012423) Copy   

•   Source: SciCrunch Registry